PL2253312T3 - Zastosowanie osmolitów uzyskiwanych z bakterii ekstremofilnych do wytwarzania wziewnych środków leczniczych do profilaktyki i leczenia chorób płucnych i sercowo-naczyniowych oraz urządzenie do inhalacji zawierające osmolity jako składnik czynny - Google Patents
Zastosowanie osmolitów uzyskiwanych z bakterii ekstremofilnych do wytwarzania wziewnych środków leczniczych do profilaktyki i leczenia chorób płucnych i sercowo-naczyniowych oraz urządzenie do inhalacji zawierające osmolity jako składnik czynnyInfo
- Publication number
- PL2253312T3 PL2253312T3 PL10008975T PL10008975T PL2253312T3 PL 2253312 T3 PL2253312 T3 PL 2253312T3 PL 10008975 T PL10008975 T PL 10008975T PL 10008975 T PL10008975 T PL 10008975T PL 2253312 T3 PL2253312 T3 PL 2253312T3
- Authority
- PL
- Poland
- Prior art keywords
- osmolytes
- cardiovascular diseases
- pulmonary
- prophylaxis
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10330768A DE10330768A1 (de) | 2003-07-07 | 2003-07-07 | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung |
| EP10008975.4A EP2253312B1 (de) | 2003-07-07 | 2004-07-02 | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eine Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung |
| EP04740552A EP1641442B1 (de) | 2003-07-07 | 2004-07-02 | Verwendung von ectoin und/oder hydroxyectoin zur herstellung von inhalierbaren arzneimitteln sowie eine dies enthaltende inhalationsvorrichtung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2253312T3 true PL2253312T3 (pl) | 2015-10-30 |
Family
ID=33559970
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04740552T PL1641442T3 (pl) | 2003-07-07 | 2004-07-02 | Zastosowanie ektoiny i/lub hydroksyektoiny do wytwarzania preparatów farmaceutycznych do inhalacji oraz zawierające je urządzenie do inhalacji |
| PL10008975T PL2253312T3 (pl) | 2003-07-07 | 2004-07-02 | Zastosowanie osmolitów uzyskiwanych z bakterii ekstremofilnych do wytwarzania wziewnych środków leczniczych do profilaktyki i leczenia chorób płucnych i sercowo-naczyniowych oraz urządzenie do inhalacji zawierające osmolity jako składnik czynny |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04740552T PL1641442T3 (pl) | 2003-07-07 | 2004-07-02 | Zastosowanie ektoiny i/lub hydroksyektoiny do wytwarzania preparatów farmaceutycznych do inhalacji oraz zawierające je urządzenie do inhalacji |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20060246007A1 (pl) |
| EP (2) | EP2253312B1 (pl) |
| JP (1) | JP2009513509A (pl) |
| AT (1) | ATE481100T1 (pl) |
| DE (2) | DE10330768A1 (pl) |
| ES (2) | ES2353962T3 (pl) |
| PL (2) | PL1641442T3 (pl) |
| WO (1) | WO2005002556A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008537734A (ja) * | 2005-03-12 | 2008-09-25 | ビトップ アクツィエンゲゼルシャフト フュール ビオテヒニシェ オプティミールング | 経口で用いられる適合溶質を含む薬剤 |
| DE102007040615A1 (de) * | 2007-08-27 | 2009-03-05 | Bitop Ag | Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen |
| DE102007052380A1 (de) * | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten |
| DE102008006780A1 (de) * | 2008-01-30 | 2009-08-06 | Bitop Ag | Verwendung von Tetrahydropyrimidinen |
| DE102008039231A1 (de) | 2008-08-22 | 2010-02-25 | Bitop Ag | Verwendung von Glucosylglycerol |
| CN102847161A (zh) * | 2011-06-30 | 2013-01-02 | 山东弘立医学动物实验研究有限公司 | 四氢嘧啶及其衍生物在制备药物肺部收促进剂中的应用 |
| DE102011113059A1 (de) | 2011-09-09 | 2013-03-14 | Bitop Ag | Therapeutische Anwendungen von Ectoin |
| ES2437690B1 (es) * | 2012-07-10 | 2014-10-24 | Chiesi Farmaceutici S.P.A. | Formulaciones inhalatorias en forma de soluciones o de polvos secos, para la eliminación de las secreciones mucosas del aparato respiratorio |
| FR3022458A1 (fr) | 2014-06-23 | 2015-12-25 | Univ Bretagne Occidentale | Utilisation du mannosylglycerate et ses derives comme agent immunostimulant |
| DE102014113781A1 (de) | 2014-09-23 | 2016-03-24 | Bitop Ag | Solut und Solutgemisch sowie eine Zusammensetzung enthaltend mindestens ein Solut zur Verwendung bei der Prävention oder Behandlung von durch Schwebstaub verursachter kosmetischer oder pathologischer Effloreszenzen |
| DE102015121050A1 (de) * | 2015-12-03 | 2017-06-08 | Bitop Ag | Kompatibles Solut oder Solutgemisch zur Verwendung bei der Prävention oder Behandlung von Krankheiten mit Barrieredefekten in Epithelgeweben |
| DE102016104470A1 (de) | 2016-03-11 | 2017-09-14 | Bitop Ag | Zusammensetzung zur Förderung der Aktivität von Sirtuinen |
| DE102020112603A1 (de) * | 2020-05-10 | 2021-11-11 | Bitop Aktiengesellschaft | Kompatible Solute zur Prävention oder Behandlung von SARS-CoV-2-Infektionen |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0385433U (pl) * | 1989-09-28 | 1991-08-29 | ||
| DE4244580A1 (de) | 1992-12-31 | 1994-07-07 | Galinski Erwin A | Verfahren zur in vivo Gewinnung von Inhaltsstoffen aus Zellen |
| DE4342560A1 (de) | 1993-12-14 | 1995-06-22 | Marbert Gmbh | Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten |
| SE9601396D0 (sv) * | 1996-04-12 | 1996-04-12 | Dieter Haeussinger | New therapeutic treatment 2 |
| US5880098A (en) * | 1996-04-12 | 1999-03-09 | Pharmacia & Upjohn Aktiebolag | Therapeutic treatment |
| DE19933460A1 (de) | 1998-07-10 | 2000-01-13 | Beiersdorf Ag | Verwendung von Ectoinen und sulfonierten UV-Filtern |
| DE19834816A1 (de) | 1998-08-01 | 2000-02-03 | Merck Patent Gmbh | Verwendung von Ectoin oder Ectoin-Derivaten in kosmetischen Formulierungen |
| WO2000056403A1 (en) * | 1999-03-19 | 2000-09-28 | The Brigham And Women's Hospital, Inc. | UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| JP2001190263A (ja) * | 1999-10-27 | 2001-07-17 | Norihiro Kurihara | タバコ穴あけ具 |
| DE10006578C2 (de) | 2000-02-14 | 2002-10-31 | Bitop Ag | Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren |
| DE10014631A1 (de) | 2000-03-24 | 2001-09-27 | Merck Patent Gmbh | Verwendung von Ectoin oder Ectoin-Derivaten zur Prophylaxe und/oder Behandlung von UV-induzierter Immunsuppression |
| US20030147937A1 (en) * | 2000-04-12 | 2003-08-07 | Thomas Schwarz | Use of compatible solutes as substances having free radical scavenging properties |
| US6716819B2 (en) * | 2000-05-19 | 2004-04-06 | University Of Iowa Research Foundation | Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections |
| DE10044985B4 (de) * | 2000-09-11 | 2019-08-14 | Merck Patent Gmbh | Verwendung von Ectoin oder Ectoin-Derivaten zum Schutz vor Allergenen |
| DE10047444A1 (de) | 2000-09-21 | 2002-04-11 | Bitop Gmbh | Verfahren zur Trennung und hochreinen Isolierung von niedermolekularen, strukturell ähnlichen Verbindungen insbesondere von Tetrahydropyrimidinderivaten wie z.B. 1,4,5,6-Tetrahydro-2-methyl-4-pyrimidincarbonsäuren (Ectoine) und deren Spaltprodukte |
| FR2819411B1 (fr) * | 2001-01-18 | 2003-02-21 | Oreal | Composition cosmetique irisee et ses utilisations |
| FR2826011B1 (fr) * | 2001-06-14 | 2004-12-10 | Oreal | Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique |
-
2003
- 2003-07-07 DE DE10330768A patent/DE10330768A1/de not_active Withdrawn
-
2004
- 2004-07-02 WO PCT/EP2004/007189 patent/WO2005002556A1/de active Application Filing
- 2004-07-02 PL PL04740552T patent/PL1641442T3/pl unknown
- 2004-07-02 ES ES04740552T patent/ES2353962T3/es not_active Expired - Lifetime
- 2004-07-02 EP EP10008975.4A patent/EP2253312B1/de not_active Expired - Lifetime
- 2004-07-02 ES ES10008975.4T patent/ES2542177T3/es not_active Expired - Lifetime
- 2004-07-02 US US10/563,587 patent/US20060246007A1/en not_active Abandoned
- 2004-07-02 DE DE502004011662T patent/DE502004011662D1/de not_active Expired - Lifetime
- 2004-07-02 EP EP04740552A patent/EP1641442B1/de not_active Expired - Lifetime
- 2004-07-02 PL PL10008975T patent/PL2253312T3/pl unknown
- 2004-07-02 AT AT04740552T patent/ATE481100T1/de active
- 2004-07-02 JP JP2006518091A patent/JP2009513509A/ja active Pending
-
2011
- 2011-03-02 US US13/038,641 patent/US20110152294A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2253312A3 (de) | 2011-07-13 |
| EP2253312A2 (de) | 2010-11-24 |
| EP1641442B1 (de) | 2010-09-15 |
| EP2253312B1 (de) | 2015-04-15 |
| ATE481100T1 (de) | 2010-10-15 |
| JP2009513509A (ja) | 2009-04-02 |
| DE502004011662D1 (de) | 2010-10-28 |
| US20060246007A1 (en) | 2006-11-02 |
| ES2542177T3 (es) | 2015-07-31 |
| EP1641442A1 (de) | 2006-04-05 |
| US20110152294A1 (en) | 2011-06-23 |
| WO2005002556A1 (de) | 2005-01-13 |
| PL1641442T3 (pl) | 2011-04-29 |
| ES2353962T3 (es) | 2011-03-08 |
| DE10330768A1 (de) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ585856A (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
| TWI359675B (en) | Bronchodilating β-agonist compositions | |
| NZ585857A (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
| PL2253312T3 (pl) | Zastosowanie osmolitów uzyskiwanych z bakterii ekstremofilnych do wytwarzania wziewnych środków leczniczych do profilaktyki i leczenia chorób płucnych i sercowo-naczyniowych oraz urządzenie do inhalacji zawierające osmolity jako składnik czynny | |
| JP2012526084A (ja) | 濃縮肥満細胞安定化用薬学的調合物 | |
| ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
| MA26892A1 (fr) | Formulations pharmaceutiques sous forme de comprimes pour inhalateurs a parer | |
| SG169233A1 (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
| GB2430623A (en) | Medicaments for treating chronic respiratory disease | |
| WO2020181138A1 (en) | Inhibiting viral and bacterial activity using low concentration hypochlorous acid solutions | |
| JP2011225625A (ja) | 肺障害の治療 | |
| JP2018532710A (ja) | 細気管支炎を有する乳幼児のための一酸化窒素吸入療法 | |
| WO2005041921A3 (en) | Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor | |
| BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| US11278602B2 (en) | Medicine for Covid-19 and treatment | |
| WO2015014209A1 (zh) | 稳定渗透压的丙酮酸药物组成及其在健康人和肺病病人中的排毒作用 | |
| AP2002002624A0 (en) | Use of a combination of compounds in a dry powder inhaler. | |
| JP2004529108A5 (pl) | ||
| JP2005508963A5 (pl) | ||
| JP2023551989A (ja) | 生成物送達デバイス及び方法 | |
| WO2010009288A1 (en) | Compositions and uses of antiviral active pharmaceutical agents | |
| JP2010189301A (ja) | 新型インフルエンザ感染症に対する医薬組成物およびその利用 | |
| WO2001062264A3 (en) | Halotherapy method by inhalation of sodium chloride | |
| CA2701388C (en) | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions | |
| US11638722B2 (en) | Medicine for Covid-19 and treatment |